09/04/2024 7:10 AM | LakeShore Biopharma Co., Ltd. (Filer) LakeShore Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024 7:40 AM | LakeShore Biopharma Co., Ltd. (Filer) LakeShore Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024 6:28 AM | LakeShore Biopharma Co., Ltd. (Filer) LakeShore Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
07/31/2024 6:15 AM | LakeShore Biopharma Co., Ltd. (Filer) LakeShore Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form NT 20-F | |
07/05/2024 6:15 AM | LakeShore Biopharma Co., Ltd. (Filer) LakeShore Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/18/2024 6:30 AM | LakeShore Biopharma Co., Ltd. (Filer) LakeShore Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/10/2024 6:01 AM | LakeShore Biopharma Co., Ltd. (Filer) LakeShore Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
05/24/2024 6:45 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024 3:30 PM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/20/2024 3:16 PM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/08/2024 7:32 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 424B3 | |
04/29/2024 7:15 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024 7:03 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024 7:15 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2024 7:20 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/03/2024 7:10 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/05/2024 7:06 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/23/2024 7:15 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024 5:17 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/16/2024 7:25 PM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/16/2024 3:14 PM | YS Biopharma Co., Ltd. (Subject) YS Biopharma Co., Ltd. (Subject) Lakeshore Biopharma (Subject) Zhang /MD Yi (Filed by)
| Form SC 13G/A | |
02/14/2024 10:23 AM | Wong Fung Ching (Filed by) YS Biopharma Co., Ltd. (Subject) YS Biopharma Co., Ltd. (Subject) Lakeshore Biopharma (Subject)
| Form SC 13D | |
02/14/2024 6:59 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024 7:01 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024 7:05 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/09/2024 6:10 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/25/2024 11:15 PM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form EFFECT | |
01/26/2024 5:03 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/23/2024 3:18 PM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form POS AM | |
01/22/2024 4:10 PM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024 6:10 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023 11:43 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023 5:37 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2023 7:45 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2023 7:46 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 424B3 | |
10/26/2023 7:45 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2023 8:10 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2023 8:13 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 424B3 | |
09/25/2023 5:12 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 424B3 | |
09/25/2023 5:07 AM | YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)
| Form 424B3 | |